| Schedule of financial statements |
|
|
Three Months Ended September 30, 2019 |
|
|
|
|
As reported
|
|
Adjustment
|
|
As revised
|
|
| Condensed Consolidated Statements of Operations |
|
|
|
|
|
|
|
| Cost of revenue |
|
$ |
1,397,361 |
|
$ |
(17,660
|
) |
$ |
1,379,701 |
|
| Gross profit |
|
|
1,795,529 |
|
|
17,660 |
|
|
1,813,189 |
|
| Product development |
|
|
1,130,880 |
|
|
(519,978
|
) |
|
610,902 |
|
| Selling, general and administrative |
|
|
3,583,815 |
|
|
17,899 |
|
|
3,601,714 |
|
| Net loss |
|
|
(2,846,071
|
) |
|
519,739 |
|
|
(2,326,332
|
) |
| Net loss per share
|
|
|
(0.26
|
) |
|
—
|
|
|
(0.21
|
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, 2019 |
|
|
|
As reported |
|
Adjustment |
|
As revised |
|
| Condensed Consolidated Statements of Operations |
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue
|
|
$ |
1,638,840 |
|
$ |
(23,601
|
) |
$ |
1,615,239 |
|
| Gross profit |
|
|
1,667,363 |
|
|
23,601 |
|
|
1,690,964 |
|
| Product development |
|
|
1,261,509 |
|
|
(638,008
|
) |
|
623,501 |
|
| Selling, general and administrative |
|
|
4,796,404 |
|
|
86,768 |
|
|
4,883,172 |
|
| Net loss |
|
|
(4,338,536
|
) |
|
574,841 |
|
|
(3,763,695
|
) |
| Net loss per share |
|
|
(0.40
|
) |
|
— |
|
|
(0.34
|
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended December 31, 2019
|
|
|
|
As reported |
|
Adjustment |
|
As revised |
|
| Condensed Consolidated Statements of Operations |
|
|
|
|
|
|
|
|
|
|
| Cost of revenue |
|
$
|
3,036,201 |
|
$ |
(41,261
|
) |
$ |
2,994,940 |
|
| Gross profit |
|
|
3,462,892 |
|
|
41,261 |
|
|
3,504,153 |
|
| Product development |
|
|
2,392,389 |
|
|
(1,157,986
|
) |
|
1,234,403 |
|
| Selling, general and administrative |
|
|
8,380,219 |
|
|
104,667 |
|
|
8,484,886 |
|
| Net loss |
|
|
(7,184,607
|
) |
|
1,094,580 |
|
|
(6,090,027
|
) |
| Net loss per share |
|
|
(0.66
|
) |
|
— |
|
|
(0.56
|
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2020 |
|
|
|
As reported
|
|
Adjustment |
|
As revised |
|
| Condensed Consolidated Statement of Operations |
|
|
|
|
|
|
|
|
|
|
| Cost of revenue |
|
$ |
1,420,909 |
|
$ |
(24,690
|
) |
$ |
1,396,219 |
|
| Gross profit |
|
|
1,649,637 |
|
|
24,690 |
|
|
1,674,327 |
|
| Product development |
|
|
1,632,353 |
|
|
(757,566
|
) |
|
874,787 |
|
| Selling, general and administrative |
|
|
5,500,837 |
|
|
177,405 |
|
|
5,678,242 |
|
| Net loss |
|
|
(5,348,980
|
) |
|
604,851 |
|
|
(4,744,129
|
) |
| Net loss per share |
|
|
(0.43
|
) |
|
— |
|
|
(0.38
|
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended March 31, 2020 |
|
|
|
As reported
|
|
Adjustment
|
|
As revised
|
|
| Condensed Consolidated Statements of Operations |
|
|
|
|
|
|
|
|
|
|
| Cost of revenue |
|
$ |
4,457,110 |
|
$ |
(65,951
|
) |
$ |
4,391,159 |
|
| Gross profit |
|
|
5,112,529 |
|
|
65,951 |
|
|
5,178,480 |
|
|
Product development
|
|
|
4,024,742 |
|
|
(1,915,552
|
) |
|
2,109,190 |
|
| Selling, general and administrative |
|
|
13,881,056 |
|
|
282,072 |
|
|
14,163,128 |
|
| Net loss |
|
|
(12,533,587
|
) |
|
1,699,431 |
|
|
(10,834,156
|
) |
| Net loss per share |
|
|
(1.11
|
) |
|
— |
|
|
(0.96
|
) |
|